These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 32559010)
1. Author Reply to: "A case of HRAS Q61-mutated metaplastic breast carcinoma associated with squamous metaplasia: Which came first, metaplasia or neoplasia?". Febres-Aldana CA; Alvarez Moreno JC; Rivera M; Kaplan S; Paramo J; Poppiti R Pathol Int; 2020 Sep; 70(9):686-688. PubMed ID: 32559010 [No Abstract] [Full Text] [Related]
2. A case of HRAS Q61-mutated metaplastic breast carcinoma associated with squamous metaplasia: Which came first, metaplasia or neoplasia? Otani T Pathol Int; 2020 Aug; 70(8):587. PubMed ID: 32342612 [No Abstract] [Full Text] [Related]
3. Understanding the histogenesis of a HRAS-PIK3R1 co-driven metastatic metaplastic breast carcinoma associated with squamous metaplasia of lactiferous ducts. Febres-Aldana CA; Alvarez Moreno JC; Rivera M; Kaplan S; Paramo J; Poppiti R Pathol Int; 2020 Feb; 70(2):101-107. PubMed ID: 31867792 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical assessment of HRAS Q61R mutations in breast adenomyoepitheliomas. Pareja F; Toss MS; Geyer FC; da Silva EM; Vahdatinia M; Sebastiao APM; Selenica P; Szatrowski A; Edelweiss M; Wen HY; Mihai R; Varga Z; Foschini MP; Rubin BP; Ellis IO; Chandarlapaty S; Jungbluth AA; Brogi E; Weigelt B; Reis-Filho JS; Rakha EA Histopathology; 2020 May; 76(6):865-874. PubMed ID: 31887226 [TBL] [Abstract][Full Text] [Related]
5. [Metaplastic breast cancer]. Volchenko NN; Frank GA; Iakubovskaia RI; Karmakova TA Arkh Patol; 1996; 58(1):10-4. PubMed ID: 8929129 [TBL] [Abstract][Full Text] [Related]
6. A Case of Metastatic Malignant Breast Adenomyoepithelioma With a Codon-61 Mutation of HRAS. Watanabe S; Otani T; Iwasa T; Takahama T; Takeda M; Sakai K; Nishio K; Ito A; Nakagawa K Clin Breast Cancer; 2019 Oct; 19(5):e589-e592. PubMed ID: 31301988 [No Abstract] [Full Text] [Related]
8. Mammary Epithelial-Myoepithelial Carcinoma: Report of a Case With HRAS and PIK3CA Mutations by Next-Generation Sequencing. Baum JE; Sung KJ; Tran H; Song W; Ginter PS Int J Surg Pathol; 2019 Jun; 27(4):441-445. PubMed ID: 30585117 [TBL] [Abstract][Full Text] [Related]
9. Squamous cell carcinoma of breast--report of two case. Samantaray S; Rout N; Mishra DP; Mallik RN Indian J Pathol Microbiol; 2003 Oct; 46(4):670-2. PubMed ID: 15025377 [TBL] [Abstract][Full Text] [Related]
10. P53 in squamous metaplasia: a marker for risk of respiratory tract carcinoma. Boers JE; ten Velde GP; Thunnissen FB Am J Respir Crit Care Med; 1996 Jan; 153(1):411-6. PubMed ID: 8542151 [TBL] [Abstract][Full Text] [Related]
11. CDKN2A(p16) and HRAS are frequently mutated in vulvar squamous cell carcinoma. Trietsch MD; Spaans VM; ter Haar NT; Osse EM; Peters AA; Gaarenstroom KN; Fleuren GJ Gynecol Oncol; 2014 Oct; 135(1):149-55. PubMed ID: 25072932 [TBL] [Abstract][Full Text] [Related]
12. Metaplastic carcinoma of the breast with dominant squamous and sebaceous differentiation in the primary tumor and osteochondroid metaplasia in a distant metastasis: report of a case with review of sebaceous differentiation in breast tumors. Carlucci M; Iacobellis M; Colonna F; Marseglia M; Gambarotti M; Giardina C; Bisceglia M Int J Surg Pathol; 2012 Jun; 20(3):284-96. PubMed ID: 21865268 [TBL] [Abstract][Full Text] [Related]
13. Metaplastic papillary tumour of the fallopian tube, a rare entity, analysed by next-generation sequencing. Sunitsch S; Reisinger J; Abete L; Kashofer K; Regitnig P Histopathology; 2020 May; 76(6):923-924. PubMed ID: 31811729 [No Abstract] [Full Text] [Related]
15. Metaplastic carcinoma of the breast: p53 analysis identified the same point mutation in the three histologic components. Wang X; Mori I; Tang W; Yang Q; Nakamura M; Nakamura Y; Sato M; Sakurai T; Kennichi K Mod Pathol; 2001 Nov; 14(11):1183-6. PubMed ID: 11706082 [TBL] [Abstract][Full Text] [Related]
16. Polypoid squamous cell carcinoma of the larynx. An immunohistochemical study for ras p21 and cytokeratin. Toda S; Yonemitsu N; Miyabara S; Sugihara H; Maehara N Pathol Res Pract; 1989 Dec; 185(6):860-6. PubMed ID: 2482483 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical study of ras and myc oncoproteins in apocrine breast lesions with and without papillomatosis. Agnantis NJ; Mahera H; Maounis N; Spandidos DA Eur J Gynaecol Oncol; 1992; 13(4):309-15. PubMed ID: 1325346 [TBL] [Abstract][Full Text] [Related]